All eight are
major pharmaceutical manufacturers.
In this case my investment thesis was that the PegIntron patented delivery method that Enzon had developed and successfully licensed to a couple of
major pharmaceutical manufacturers would be adopted for other drugs and that that the existing royalty streams would grow with the success of the current drugs and the addition of new ones.
Yet one thing is clear:
Major pharmaceutical manufacturers, originally skeptical about the prospects for large - molecule therapies, have long since joined the race to develop the treatments, acquiring, merging or partnering with small companies working on mAbs and other biologics.
Representation of
a major pharmaceutical manufacturer in multi-defendant actions in federal and state courts, including multiple state attorney general actions, challenging industry pricing practices
Not exact matches
Among some of the
major homegrown companies that Enterprise Investors assisted and that went public on the WSE were the First Polish - American Bank in 1994,
pharmaceuticals company Polfa Kutno in 1995 and packaging
manufacturer Grupa Kęty in 1996.
Starting in the latter half of 2015 and still unfortunately persisting, the political backdrop was a
major headwind for the entire
pharmaceutical supply chain from drug
manufacturers to pharmacies / pharmacy benefit mangers (i.e. CVS and Walgree...
Plus, we've gone far above and beyond the call of duty and chosen the same cGMP certified
pharmaceuticals manufacturer that
major retailers like Albertsons, Rite Aid, Safeway, Walgreen, Wal - Mart and more use!
It is a known fact that
major manufacturers that provide heartworm preventive, and flea and tick products, pain management medications, and other
pharmaceuticals do not directly supply these products to the 1 - 800 companies.
Dugan, Babij, Tolley & Kohler, LLC had litigated product liability cases against
major manufacturers, including General Motors Corporation, Ford Motor Company, Caterpillar, Inc., GlaxoSmithKline, Copley
Pharmaceuticals, Bausch & Lomb, Kawasaki Heavy Industries Limited and Dow Corning Corporation.
He has coordinated the national defense of several
major pharmaceutical litigations and has led teams defending
manufacturers of vaccines, blood products, automobiles, asbestos - containing products, toys and many other products.
He has extensive experience in representing a
major media company, financial institutions, brand name
pharmaceutical manufacturers, accounting firms, law firms, and a variety of other companies and professionals in federal and state litigation, including in matters involving antitrust law, securities law, corporate governance,
pharmaceutical pricing, contract disputes, accountants liability, legal malpractice and communications law.
Some of the largest
pharmaceutical drug companies and medical device
manufacturers are responsible for
major health problems plaguing American citizens.
As a partner at Langdon & Emison, Brett and his colleagues have tried cases against some of the largest corporations in the world, including all
major auto
manufacturers, railroad companies and trucking companies, as well as
major pharmaceutical and medical device companies.
Clients range from governments to
major global
pharmaceutical manufacturers to start - up companies that are inventing new medical drugs.
Our present and recent engagements as national coordinating counsel in
major pharmaceutical and medical device litigation involve numerous products for many of the world's largest
pharmaceutical manufacturers.